Clariant Valuation

Q: What is the Fair Price of CLZN.Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CLZN.Y ($12.03) is trading above our estimate of [[fair value]] ($11.26)

Is CLZN.Y undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLZN.Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLZN.Y ($12.03) is trading above our estimate of fair value ($11.26)

Significantly Below Fair Value: CLZN.Y is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLZN.Y?

Key metric: As CLZN.Y is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CLZN.Y. This is calculated by dividing CLZN.Y's market cap by their current earnings.
What is CLZN.Y's PE Ratio?
PE Ratio	29.6x
Earnings	CHF 118.00m
Market Cap	CHF 3.49b

CLZN.Y key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	9.2x
PEG Ratio	1x

Price to Earnings Ratio vs Peers

How does CLZN.Y's PE Ratio compare to its peers?

The above table shows the PE ratio for CLZN.Y vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.4x
FUL H.B. Fuller	22.8x	14.1%	US$4.2b
ASH Ashland	18.5x	5.0%	US$3.7b
AVNT Avient	31.4x	20.4%	US$4.8b
SXT Sensient Technologies	36.8x	20.2%	US$3.3b
CLZN.Y Clariant	29.6x	29.4%	US$3.5b

Price-To-Earnings vs Peers: CLZN.Y is expensive based on its Price-To-Earnings Ratio (29.6x) compared to the peer average (27.4x).

Price to Earnings Ratio vs Industry

How does CLZN.Y's PE Ratio compare vs other companies in the US Chemicals Industry?

7 Companies	Price / Earnings	Estimated Growth	Market Cap
FFHL Fuwei Films (Holdings)	2.8x	n/a	US$27.11m
BSLK Bolt Projects Holdings	0.06x	n/a	US$10.03m
BON Bon Natural Life	3x	n/a	US$7.46m
GSPI Green Star Products	1.7x	n/a	US$1.49m

7 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: CLZN.Y is expensive based on its Price-To-Earnings Ratio (29.6x) compared to the US Chemicals industry average (22.9x).

Price to Earnings Ratio vs Fair Ratio

What is CLZN.Y's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLZN.Y PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	29.6x
Fair PE Ratio	29x

Price-To-Earnings vs Fair Ratio: CLZN.Y is expensive based on its Price-To-Earnings Ratio (29.6x) compared to the estimated Fair Price-To-Earnings Ratio (29x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ecora Resources

UK£163.0m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.81

-4.6%

-30.1%

CMOC Group

HK$159.6b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.70

-9.4%

19.6%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.16

-0.5%

25.0%